<http://schema.org/url>
<https://www.genengnews.com/>
<http://www.genengnews.com/Registration.aspx?ReturnURL=%2Fgen-news-highlights%2Fallergan-licenses-molecular-partners-phase-ii-eye-disease-protein-therapeutic-for-45m%2F81245102%2F>